GlaxoSmithKline (GSK) on Monday became the latest multinational to boost its investments in India, with a £629 million ($1 billion) offer to increase its stake in its India-listed drug unit
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.
